Cargando…

Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP

The sodium taurocholate co-transporting polypeptide (NTCP, SLC10A1) is the main hepatic transporter of conjugated bile acids, and the entry receptor for hepatitis B virus (HBV) and hepatitis delta virus (HDV). Myrcludex B, a synthetic peptide mimicking the NTCP-binding domain of HBV, effectively blo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donkers, Joanne M., Zehnder, Benno, van Westen, Gerard J. P., Kwakkenbos, Mark J., IJzerman, Adriaan P., Oude Elferink, Ronald P. J., Beuers, Ulrich, Urban, Stephan, van de Graaf, Stan F. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681660/ https://www.ncbi.nlm.nih.gov/pubmed/29127322 http://dx.doi.org/10.1038/s41598-017-15338-0

Ejemplares similares

NTCP deficiency in mice protects against obesity and hepatosteatosis
por: Donkers, Joanne M., et al.
Publicado: (2019)

Mechanistic insights into the inhibition of NTCP by myrcludex B
por: Donkers, Joanne M., et al.
Publicado: (2019)

Bile Salts by the Back Road
por: Oude Elferink, Ronald P.J., et al.
Publicado: (2023)

Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice
por: Slijepcevic, Davor, et al.
Publicado: (2017)

Targeting the Four Pillars of Enterohepatic Bile Salt Cycling; Lessons From Genetics and Pharmacology
por: Kunst, Roni F., et al.
Publicado: (2021)

Insufficient evidence for NTCP activity in stellate cells
por: Kunst, Roni F, et al.
Publicado: (2022)

Inhibition of Hepatic Bile Acid Uptake by Myrcludex B Promotes Glucagon-Like Peptide-1 Release and Reduces Obesity
por: Donkers, Joanne M., et al.
Publicado: (2020)

The Lipid Raft Component Stomatin Interacts with the Na(+) Taurocholate Cotransporting Polypeptide (NTCP) and Modulates Bile Salt Uptake
por: Appelman, Monique D., et al.
Publicado: (2020)

NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry
por: Watashi, Koichi, et al.
Publicado: (2014)

Innovative HBV Animal Models Based on the Entry Receptor NTCP
por: Wettengel, Jochen M., et al.
Publicado: (2020)

Primary biliary cirrhosis
por: Hohenester, Simon, et al.
Publicado: (2009)

Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+)-taurocholate cotransporting polypeptide knockout mice
por: Slijepcevic, Davor, et al.
Publicado: (2015)

Perfluoroalkyl Carboxylic Acids Interact with the Human Bile Acid Transporter NTCP
por: Ruggiero, Melissa J., et al.
Publicado: (2021)

Quantitative prediction of selectivity between the A(1) and A(2A) adenosine receptors
por: Burggraaff, Lindsey, et al.
Publicado: (2020)

Structural insights into the HBV receptor and bile acid transporter NTCP
por: Park, Jae-Hyun, et al.
Publicado: (2022)

Autotaxin, PPARs, and FGF21: An Eye Opener for Progressive Liver Disease?
por: Beuers, Ulrich, et al.
Publicado: (2022)

NTCP Deficiency Affects the Levels of Circulating Bile Acids and Induces Osteoporosis
por: Yang, Fangji, et al.
Publicado: (2022)

Curcumin inhibited hepatitis B viral entry through NTCP binding
por: Thongsri, Piyanoot, et al.
Publicado: (2021)

An exploration strategy improves the diversity of de novo ligands using deep reinforcement learning: a case for the adenosine A(2A) receptor
por: Liu, Xuhan, et al.
Publicado: (2019)

DrugEx v3: scaffold-constrained drug design with graph transformer-based reinforcement learning
por: Liu, Xuhan, et al.
Publicado: (2023)

Na(+)‐taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice
por: Slijepcevic, Davor, et al.
Publicado: (2018)

Soluble Adenylyl Cyclase Regulates Bile Salt‐Induced Apoptosis in Human Cholangiocytes
por: Chang, Jung‐Chin, et al.
Publicado: (2016)

Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo
por: van Dijk, Remco, et al.
Publicado: (2017)

Cholestasis-Associated Pruritus and Its Pruritogens
por: Langedijk, Jacqueline A. G. M., et al.
Publicado: (2021)

Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment
por: Li, Yan, et al.
Publicado: (2022)

Structure of human NTCP reveals the basis of recognition and sodium-driven transport of bile salts into the liver
por: Liu, Hongtao, et al.
Publicado: (2022)

N-Glycosylation of the Na+-Taurocholate Cotransporting Polypeptide (NTCP) Determines Its Trafficking and Stability and Is Required for Hepatitis B Virus Infection
por: Appelman, Monique D., et al.
Publicado: (2017)

Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice
por: Kunst, Roni F., et al.
Publicado: (2022)

Significantly Improved HIV Inhibitor Efficacy Prediction Employing Proteochemometric Models Generated From Antivirogram Data
por: van Westen, Gerard J. P., et al.
Publicado: (2013)

DrugEx v2: de novo design of drug molecules by Pareto-based multi-objective reinforcement learning in polypharmacology
por: Liu, Xuhan, et al.
Publicado: (2021)

Annotation of Allosteric Compounds to Enhance Bioactivity Modeling for Class A GPCRs
por: Burggraaff, Lindsey, et al.
Publicado: (2020)

Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening
por: Paricharak, Shardul, et al.
Publicado: (2016)

IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection
por: Palatini, Massimo, et al.
Publicado: (2022)

Symptom patterns in the daily life of PSC patients
por: van Munster, Kim N., et al.
Publicado: (2022)

Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity
por: Shimura, Satomi, et al.
Publicado: (2017)

Intestinal Farnesoid X Receptor Activation by Pharmacologic Inhibition of the Organic Solute Transporter α-β
por: van de Wiel, Sandra M.W., et al.
Publicado: (2017)

Three “hotspots” important for adenosine A(2B) receptor activation: a mutational analysis of transmembrane domains 4 and 5 and the second extracellular loop
por: Peeters, Miriam C., et al.
Publicado: (2011)

Deciphering conformational selectivity in the A(2A) adenosine G protein-coupled receptor by free energy simulations
por: Jespers, Willem, et al.
Publicado: (2021)

Cancer-Related Somatic Mutations in Transmembrane Helices Alter Adenosine A1 Receptor Pharmacology
por: Wang, Xuesong, et al.
Publicado: (2022)

Proteochemometric Modeling Identifies Chemically Diverse Norepinephrine Transporter Inhibitors
por: Bongers, Brandon J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cf750murk4m05ronvhfcq6b1ic